Connection
David Camidge to Receptor, ErbB-4
This is a "connection" page, showing publications David Camidge has written about Receptor, ErbB-4.
|
|
Connection Strength |
|
 |
|
 |
|
0.023 |
|
|
|
-
J?nne PA, Boss DS, Camidge DR, Britten CD, Engelman JA, Garon EB, Guo F, Wong S, Liang J, Letrent S, Millham R, Taylor I, Eckhardt SG, Schellens JH. Phase I dose-escalation study of the pan-HER inhibitor, PF299804, in patients with advanced malignant solid tumors. Clin Cancer Res. 2011 Mar 01; 17(5):1131-9.
Score: 0.023